Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)RPM CD19-mbIL15-CAR-T Cells in Patient With Advanced Lymphoid Malignancies
Phase 1
Terminated
- Conditions
- Non-Hodgkin's Lymphoma RefractoryFollicular LymphomaMantle Cell LymphomaNon-Hodgkin's Lymphoma, RelapsedPrimary Mediastinal Large B Cell LymphomaB-cell Acute Lymphoblastic LeukemiaDiffuse Large B Cell LymphomaHigh-grade B-cell Lymphoma
- First Posted Date
- 2021-04-14
- Last Posted Date
- 2022-05-18
- Lead Sponsor
- Eden BioCell Ltd.
- Target Recruit Count
- 2
- Registration Number
- NCT04844086
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei, Taiwan
News
No news found